Hire an Advanced Robo-Advisor to Trade AMGN on Your Behalf.
- Street Sentiment
- Personalized Strategy
- Free Trading Simulator
Course of Action
Sentiment (10 days)
- Strong Buy
- Strong Sell
DAILY PRICE CHANGE VS SENTIMENT
Why Invest Using a Robo-Advisor?
Smart Auto-Trading is an advanced robo-advisor designed to automate securities investing. Its robo is designed to screens, monitors and auto-trades elite stocks like AMGEN INC. (AMGN) using artificial intelligence, social media and market data. Using Smart Auto-Trading in your brokerage account holds the potential to accelerate your financial performance.
Converting your 401k to a Rollover IRA and auto-trade in it using Smart Auto-Trading from Stock Circles could be a great strategy to grow your retirement account while you work. Smart Auto-Trading is an actively trading robo-advisor that auto-trades the S&P 500 on your behalf.
Based on historical performance, Smart Auto-Trading's model strategies have displayed the potential to increase yield and grow retirement accounts quicker than if you were to use a passive investment method using the same securities. Active trading is a systematic investment strategy that uses price momentum, short-term trades and compounding to build wealth.
In the past 2 years, the system has produced great results. Smart Auto-Trading makes short-term trades. If these trades happen in a tax-deferred account, you do not get taxed until you start taking money out of the account. So if you start auto-trading today in your retirement account and auto-trade for 10, 20, 30 years, imagine how much money this automated strategy as the potential to create for you.
This investment system works great for tax-deferred accounts like Keogh, SIMPLE IRA, traditional IRA, IRA, Rollover IRA, 529 College plans and UGMA and you can trade with a minimum of $5,000 in your account.
Smart Auto-Trading is very affordable. You will pay a low monthly fee to use it. Using Smart Auto-Trading will usually pay for itself on the first successful trade of the month.
Robo investing is super easy
Robo-investing with Smart Auto-Trading is easy. You do not need to know anything about stock investing. All you need to do is to setup your trading strategy and the trading robot will take care of the rest. Stock Circles offers a default strategy to help you get started. You can test the strategy in simulation mode free of charge today. Once comfortable with the outcome, you are ready to trade real money. You can then connect Smart Auto-Trading to your brokerage account and start to auto-trade.
Past performance does not guarantee future success. Smart Auto-Trading will do its best to take advantage of the market but if the market goes down for a long period of time then there is no money to be made than everyone is affected. Robo-Advisors like Smart Auto-Trading are good at what they do but they don’t have super powers.
Smart Auto-Trading trades only elite stocks. By trading the S&P 500, Nasdaq 100 and Dow 30, Smart Auto-Trading uses widely traded stocks.
Smart Auto-Trading uses Artificial Intelligence concepts to screen, monitor and auto-trade stocks. It monitors and trades on your behalf while you attend more important life events.
Take advantage of active trading today by registering at stockcircles.com It's free to start in simulation mode.
There are clear benefits associated with using a robo-advisor such as Smart Auto-Trading to help you reach your financial goals. Smart Auto-Trading simplifies stock investing down to a few steps. It auto-trades for you, using your personalized strategy, while you attend more important life events.
Using Smart Auto-Trading is like having thousands of traders working for you to help you reach your financial goals.
Smart Auto-Trading actively trades which is different from passive investing. The robo is on the lookout working to maximize your potential every business day of the year. It trades on the news taking advantage of price changes and trends by listening into trader's communications and by validating this information with market data.
Smart Auto-Trading is one of the first robo-advisor to take advantage of Government grade listening technology, artificial intelligence, social media and market data natively.
Try Smart Auto-Trading today!
You can test Smart Auto-Trading in simulation mode, risk free, Stock Circles today.
Disclaimer: Past performance may not be indicative of future results. Therefore, you should assume that the future performance of any specific investment, investment strategy (including robo-strategies), or product made in reference directly or indirectly on this website, will be profitable or equal to corresponding indicated performance levels. Robot-Advisors like other investment methods rely on favorable market conditions to provide positive outcomes.
AMGEN INC. (AMGN) News
Amgen Inc. (NASDAQ:AMGN) Holdings Boosted by Xact Kapitalforvaltning AB
Xact Kapitalforvaltning AB increased its holdings in shares of Amgen Inc. (NASDAQ:AMGN) by 1.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 124,819 shares of the medical research company’s stock after purchasing an additional 1,722 shares during the period. Xact Kapitalforvaltning AB’s holdings in Amgen were worth $21,498,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in AMGN. TrimTabs Asset Management LLC increased its position in shares of Amgen by 88.9% during the 1st quarter. TrimTabs Asset Management LLC now owns 612 shares of the medical research company’s stock worth $100,000 after purchasing an additional 288 shares during the last quarter. Alpha Omega Wealth Management LLC increased its position in shares of Amgen by 19.0% during the 1st quarter. Alpha Omega Wealth Management LLC now owns 625 shares of the medical research company’s stock worth $103,000 after purchasing an additional 100 shares during the last quarter. Jackson Grant Investment Advisers Inc. increased its position in shares of Amgen by 0.6% during the 1st quarter. Jackson Grant Investment Advisers Inc. now owns 636 shares of the medical research company’s stock worth $104,000 after purchasing an additional 4 shares during the last quarter. American Beacon Advisors Inc. acquired a new position in shares of Amgen during the 1st quarter worth approximately $106,000. Finally, Nelson Roberts Investment Advisors LLC acquired a new position in shares of Amgen during the 1st quarter worth approximately $121,000. Institutional investors and hedge funds own 78.09% of the company’s stock.
A number of research analysts recently weighed in on the company. Oppenheimer Holdings, Inc. reissued an “outperform” rating and set a $189.00 target price on shares of Amgen in a report on Friday, June 30th. BidaskClub raised Amgen from a “buy” rating to a “strong-buy” rating in a report on Friday, June 23rd. Credit Suisse Group set a $177.00 price target on Amgen and gave the company a “hold” rating in a research note on Friday, July 14th. Morgan Stanley boosted their price target on Amgen from $183.00 to $184.00 and gave the company an “overweight” rating in a research note on Tuesday, June 13th. Finally, Deutsche Bank AG restated a “hold” rating and issued a $174.00 price target (up from $172.00) on shares of Amgen in a research note on Wednesday, July 26th. One research analyst has rated the stock with a sell rating, twelve have given a hold rating, eleven have assigned a buy rating and two have given a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $186.14.
Shares of Amgen Inc. (NASDAQ AMGN) traded down 0.47% on Friday, reaching $185.76. The company’s stock had a trading volume of 2,275,630 shares. The company has a market cap of $135.54 billion, a P/E ratio of 16.92 and a beta of 1.35. Amgen Inc. has a 12-month low of $133.64 and a 12-month high of $191.10. The company’s 50 day moving average price is $175.99 and its 200 day moving average price is $169.31.
Amgen (NASDAQ:AMGN) last issued its quarterly earnings data on Tuesday, July 25th. The medical research company reported $3.27 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.11 by $0.16. The company had revenue of $5.81 billion for the quarter, compared to analyst estimates of $5.67 billion. Amgen had a net margin of 35.46% and a return on equity of 29.85%. Amgen’s revenue was up 2.1% compared to the same quarter last year. During the same period last year, the company posted $2.84 earnings per share. Analysts forecast that Amgen Inc. will post $12.57 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 8th. Investors of record on Thursday, August 17th were issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.48%. The ex-dividend date was Tuesday, August 15th. Amgen’s payout ratio is 41.93%.Get Started today! - Risk Free